Venture Capital

Pendulum Therapeutics Announces Publication Of Clinical Data For First-ever Medical Probiotic That Provides The Dietary Management Of Healthy A1c And Blood Glucose Levels

by prnewswire.com posted 12months ago 267 views
Pioneering Microbiome Company Demonstrates Significant Clinical Results from Use of Microbiome-Based Synbiotic in Patients with Type 2 Diabetes SAN FRANCISCO, July 20, 2020 /PRNewswire/ -- Pendulum Therapeutics, an evidence-based microbiome company, announced today the publication of their clinical study in the journal BMJ Open Diabetes Research & Care showing the effectiveness of Pendulum's novel medical probiotic, Pendulum Glucose Control.

In this article